Cardiol Therapeutics (CRDL) Invested Capital (2021)
Cardiol Therapeutics (CRDL) posted Invested Capital of $3.9 million for Q4 2021.
Cardiol Therapeutics (CRDL) Invested Capital (2021) Analysis & Trends
Cardiol Therapeutics' Invested Capital history runs 1 years deep, the most recent figure standing at $3.9 million for Q4 2021.
- Quarterly Invested Capital changed N/A year-over-year to $3.9 million in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $3.9 million (changed N/A YoY) and the FY2021 annual result came in at $4.0 million, changed N/A from the prior year.
- Invested Capital was $3.9 million for Q4 2021 at Cardiol Therapeutics.
- Across five years, Invested Capital topped out at $3.9 million in Q4 2021 and bottomed at $3.9 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Cardiol Therapeutics | 134.05 Mn | 134.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 3.95 Mn |